Annovis Bio, Inc. Profile Avatar - Palmy Investing

Annovis Bio, Inc.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…

Biotechnology
US, Berwyn [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ANVS's Analysis
CIK: 1477845 CUSIP: 03615A108 ISIN: US03615A1088 LEI: - UEI: -
Secondary Listings
ANVS has no secondary listings inside our databases.